Aclaris Therapeutics, Inc. (ACRS) Social Stream
ACLARIS THERAPEUTICS INC (ACRS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ACLARIS THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-20 | 4 | $50 | $26 | $34 | $8.24 | 312.62% |
| 2022-08-01 | 5 | $50 | $26 | $34.8 | $8.24 | 322.33% |
| 2022-08-08 | 6 | $50 | $26 | $34.8 | $8.24 | 322.33% |
| 2022-10-06 | 6 | $50 | $26 | $34.333 | $8.24 | 316.66% |
| 2022-11-09 | 7 | $50 | $26 | $34.333 | $8.24 | 316.66% |
| 2022-12-01 | 8 | $50 | $25 | $33 | $8.24 | 300.49% |
| 2023-02-24 | 9 | $50 | $25 | $32.5 | $8.24 | 294.42% |
| 2023-03-01 | 9 | $50 | $25 | $33.5 | $8.24 | 306.55% |
| 2023-03-07 | 9 | $43 | $11 | $30 | $8.24 | 264.08% |
| 2023-03-09 | 9 | $43 | $11 | $29.125 | $8.24 | 253.46% |
The Trend in the Analyst Price Target
ACRS's average price target has moved up $2.45 over the prior 24 months.
ACRS reports an average of 163.96% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-11 | 6 | 50 | 26 | 34.800 | 10.16 | 242.52% |
| 2022-05-20 | 5 | 50 | 26 | 34.000 | 12.11 | 180.76% |
| 2022-10-06 | 6 | 50 | 26 | 34.333 | 16.70 | 105.59% |
| 2022-11-08 | 7 | 50 | 26 | 34.333 | 16.21 | 111.8% |
| 2023-02-24 | 9 | 50 | 25 | 32.500 | 12.07 | 169.26% |
ACRS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 9 | 0 | 0 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 120 days, ACRS's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, ACLARIS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1147.24% of them.
- ACLARIS THERAPEUTICS INC's variance in analysts' estimates is lower than -922.24% of all US stocks.
- In terms of how ACLARIS THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 1059.47% of that group.
- In the context of stocks in the small market cap category, ACLARIS THERAPEUTICS INC's average analyst price target is greater than 999.88% of them.
In the Pharmaceutical Products industry, WVE, PDSB, and EPIX are the three stocks most similar to ACLARIS THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for ACRS? Use POWR Ratings for clearer insight into price direction.